Implantable Cardiac Monitors Market to Witness Exponential Growth by 2023 | Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtr

A New fresh research report presented by KD Market Insights provides a detailed analysis of “Implantable Cardiac Monitors 2017: Market Size, Trends & Opportunity Outlook – Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The research provides a complete understanding of the global Implantable Cardiac Monitors Market in terms of revenue.

An implantable cardiac monitor is a small monitoring device, which is used to record the electrical activity of the heart. The device is embedded under the skin of the patient's chest from where the heart's electrical activity is recorded. The device can be activated either by adjusting the heart rate according to the range set by the physician or can be externally triggered with the push of a button. These recordings are used by the physicians to analyze and identify an abnormal heart rhythm. The device is used to monitor patients who are at risk for myocardial infraction and atrial fibrillation. The global implantable cardiac monitors market was valued at $410.4 million in 2016, and is expected to reach at $678.3 million by 2023, registering a CAGR of 7.4% from 2017 to 2023.

Request for Sample@: https://www.kdmarketinsights.com/sample/5149

A major factor that drives implantable cardiac monitors market is their longevity. In addition, the implantable nature does not require any admission to the hospital, and the patient can be monitored while performing the daily activities. Moreover, rise in incidence of patients suffering from atrial fibrillation, increase in prevalence of myocardial infraction, and unhealthy lifestyle are some other factors that boost the market growth. However, availability of alternative mode of treatment and inflated cost of device hamper the market growth. Conversely, increase in awareness among patients these devices and treatment options for management of cardiac disorders provide lucrative market growth opportunities.

The global implantable cardiac monitors market is segmented based on indication, end user, and region. Based on indication, the market is divided into cardiac arrhythmias, atrial fibrillation, and epilepsy & unexplained falls. By end user, it is classified into hospitals, cardiac centers & clinics and ambulatory surgical centers (ASCs).

Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016 and is expected to maintain its dominance throughout the forecast period. This is attributed to increase in development of sophisticated cardiac devices and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, due to the improvements in healthcare facilities, increase in disposable income, and improvement in economic conditions.

KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the global implantable cardiac monitors market, with current trends and future estimations to elucidate the imminent investment pockets.
– Comprehensive analysis of factors that drive and restrict the market growth is provided.
– Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable stakeholders to capitalize on the prevailing market opportunities.
– Extensive analysis of the key segments of the industry, which helps understand the type of products and technologies used globally is included.
– Key market players and their strategies are provided to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Indication
– Cardiac Arrhythmias
– Atrial Fibrillation
– Epilepsy & Unexplained Falls

By End User
– Hospitals
– Cardiac Centers & Clinics
– Ambulatory Surgical Centers (ASCs)

By Region
– North America
– – U.S.
– – Canada
– – Mexico
– Europe
– – UK
– – France
– – Germany
– – Italy
– – Spain
– – Switzerland
– – Rest of Europe
– Asia-Pacific
– – Japan
– – China
– – India
– – Australia
– – Malaysia
– – New Zealand
– – Rest of Asia-Pacific
– LAMEA
– – Brazil
– – South Africa
– – Egypt
– – Rest of LAMEA

KEY PLAYERS PROFILED
– Abbott Laboratories
– Biotronik SE & Co. KG
– Boston Scientific Corporation
– Edwards Lifescience Corporation
– General Electric Company
– Koninklijke Philips N.V.
– LivaNova PLC
– Medtronic plc
– Nihon Kohden Corporation
– Phoenix Heart Center

The other players in the value chain include (profiles not included in the report)
– Abiomed, Inc.
– Berlin Heart GmbH
– Jarvik Heart, Inc.
– ReliantHeart Inc.
– Schiller AG
– Astellas Pharma, Inc.
– Sigma-Aldrich Corporation
– Agilent Technologies, Inc.
– Basilea Pharmaceutical Ltd.

Browse Full Report & TOC: https://www.kdmarketinsights.com/product/implantable-cardiac-monitors-market-amr

Table Of Content:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2 KEY BENEFITS

1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top Winning Strategies

3.2.2.1. Top Winning Strategies, By Year, 2014-2017*
3.2.2.2. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.2.3. Top Winning Strategies, By Company, 2014-2017*

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Extended durability of implantable cardiac monitors
3.5.1.2. Less hospital stay and fewer hospital readmission
3.5.1.3. Rise in incidence of atrial fibrillation, myocardial infraction, and arrhythmias

3.5.2. Restraints

3.5.2.1. Availability of alternative mode of treatment
3.5.2.2. High cost of implantable cardiac monitors

3.5.3. Opportunity

3.5.3.1. Increase in awareness about devices and treatment options for cardiac disorders

CHAPTER 4 IMPLANTABLE CARDIAC MONITOR MARKET, BY INDICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CARDIAC ARRHYTHMIAS

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast by region
4.2.1. Market size and forecast by country

4.3. ATRIAL FIBRILLATION

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast by region
4.3.3. Market size and forecast by country

4.4. EPILEPSY & UNEXPLAINED FALLS

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast by region
4.4.3. Market size and forecast by country

CHAPTER 5 IMPLANTABLE CARDIAC MONITOR MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS

5.2.1. Market size and forecast by region
5.2.2. Market size and forecast by country

5.3. CARDIAC CENTERS & CLINICS

5.3.1. Market size and forecast by region
5.3.2. Market size and forecast by country

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast by region
5.4.2. Market size and forecast by country

CHAPTER 6 IMPLANTABLE CARDIAC MONITOR MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by country
6.2.3. North America market size and forecast, by indication
6.2.4. North America market size and forecast, by end user

6.2.4.1. U.S., market size and forecast by Indication
6.2.4.2. U.S., market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by indication
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by indication
6.2.4.6. Mexico market size and forecast, by end user

6.3. EUROPE

6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by country
6.3.3. Europe market size and forecast, by indication
6.3.4. Europe market size and forecast, by end user

6.3.4.1. Germany market size and forecast, by indication
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by indication
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by indication
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by indication
6.3.4.8. Italy market size and forecast, by end user
6.3.4.9. Spain market size and forecast, by indication
6.3.4.10. Spain market size and forecast, by end user
6.3.4.11. Switzerland market size and forecast, by indication
6.3.4.12. Switzerland market size and forecast, by end user
6.3.4.13. Rest of Europe market size and forecast, by indication
6.3.4.14. Rest of Europe market size and forecast, by end user

6.4. ASIA-PACIFIC

6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.3. Asia-Pacific market size and forecast, by indication
6.4.4. Asia-Pacific market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by indication
6.4.4.2. Japan market size and forecast, by end user
6.4.4.3. China market size and forecast, by indication
6.4.4.4. China market size and forecast, by end user
6.4.4.5. Australia market size and forecast, by indication
6.4.4.6. Australia market size and forecast, by end user
6.4.4.7. India market size and forecast, by indication
6.4.4.8. India market size and forecast, by end user
6.4.4.9. Malaysia market size and forecast, by indication
6.4.4.10. Malaysia market size and forecast, by end user
6.4.4.11. New Zealand market size and forecast, by indication
6.4.4.12. New Zealand market size and forecast, by end user
6.4.4.13. Rest of Asia-Pacific market size and forecast, by indication
6.4.4.14. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.3. LAMEA market size and forecast, by indication
6.5.4. LAMEA market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by indication
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. South Africa market size and forecast, by indication
6.5.4.4. South Africa market size and forecast, by end user
6.5.4.5. Egypt market size and forecast, by indication
6.5.4.6. Egypt market size and forecast, by end user
6.5.4.7. Rest of LAMEA market size and forecast, by indication
6.5.4.8. Rest of LAMEA market size and forecast, by end user
Continue:

Check for Discount @ https://www.kdmarketinsights.com/discount/5149

Contact Us:
KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (517) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com

About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision. Our clients list includes various Fortune 500 companies and leading advisory firms.

This release was published on openPR.